Latex Allergy Alerts in the Age of CPOE: Assessing the Risk From Injectable Medications

Wu M McIntosh J Liu J. Current prevalence rate of latex allergy: why it remains a problem? J Occup Health. 2016;58(2):138-144. doi:10.1539/joh.15-0275-RA

Latex Allergy. Asthma and Allergy Foundation of America. Published 2015. Accessed June 22, 2021. https://www.aafa.org/latex-allergy/

Federal Register. Banned Devices; Powdered Surgeon’s Gloves, Powdered Patient Examination Gloves, and Absorbable Powder for Lubricating a Surgeon’s Glove. Food and Drug Administration; 2016.

Jones JM Sussman GL Beezhold DH. Latex allergen levels of injectable collagen stored in syringes with rubber plungers. Urology. 1996;47(6):898-902. doi:10.1016/S0090-4295(96)00037-4

Primeau MN Adkinson NF Jr. Hamilton RG. Natural rubber pharmaceutical vial closures release latex allergens that produce skin reactions. J Allergy Clin Immunol. 2001;107(6):958-962. doi:10.1067/mai.2001.115630

Yunginger JW Jones RT Fransway AF Kelso JM Warner MA Hunt LW. Extractable latex allergens and proteins in disposable medical gloves and other rubber products. J Allergy Clin Immunol. 1994;93(5):836-842. doi:10.1016/0091-6749(94)90374-3

Federal Register. Recommendations for Labeling Medical Products to Inform Users That the Product or Product Container is not Made With Natural Rubber Latex; Guidance for Industry and Food and Drug Administration Staff; Availability. Food and Drug Administration; 2014.

Kuperman GJ Marston E Paterno M , et al. Creating an enterprise-wide allergy repository at partners healthcare system. AMIA Annu Symp Proc. 2003;2003:376-380.

Légat L Van Laere S Nyssen M Steurbaut S Dupont AG Cornu P. Clinical decision support systems for drug allergy checking: systematic review. J Med Internet Res. 2018;20(9): e258. doi:10.2196/jmir.8206

Hunteman L Ward L Read D Jolly M Heckman M. Analysis of allergy alerts within a computerized prescriber-order-entry system. Am J Health Syst Pharm. 2009;66(4):373-377. doi:10.2146/ajhp080328

Wynn RJ Boneberg A Lakshminrusimha S. Unexpected source of latex sensitization in a neonatal intensive care unit. J Perinatol. 2007;27(9):586-588. doi:10.1038/sj.jp.7211793

Gu YD Reynolds HH Kissel R Elewski BE. Secukinumab and latex allergies: don’t trust your EMR. J Cutan Med Surg. 2020;4(1):97-99.

Sampathi V Lerman J. Case scenario: perioperative latex allergy in children. Anesthesiology. 2011;114(3):673-680. doi:10.1097/ALN.0b013e3182084a58

American Association of Nurse Anesthetists. Latex allergy management guidelines. Published 2018. Accessed June 16, 2021. https://www.aana.com/docs/default-source/practice-aana-com-web-documents-(all)/professional-practice-manual/latex-allergy-management.pdf?sfvrsn=9c0049b1_8

Association of Surgical Technologists. Guidelines for best practices for the natural rubber latex allergic and metal allergic patient. Published 2018. Accessed June 16, 2021. http://www.ast.org/uploadedFiles/Main_Site/Content/About_Us/Guideline_Latex_Allergy.pdf

Centers for Disease Control and Prevention. Latex in vaccine packaging. Published 2020. Accessed June 16, 2021. https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/latex-table.pdf

Centers for Disease Control and Prevention. Epidemiology of vaccine preventable diseases. In: Hamborsky J Kroger A. Wolfe C , eds. The Pink Book: Course Textbook, 13th ed. Public Health Foundation; 2015.

ModernaTX, Inc. Fact sheet for healthcare providers administering vaccine (vaccination providers) Emergency Use Authorization (EUA) of the Moderna COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19). Published 2021. Accessed June 24, 2021. https://www.modernatx.com/covid19vaccine-eua/eua-fact-sheet-providers.pdf

Pfizer-BioNTech. Fact sheet for healthcare provides administering vaccine (vaccination providers) Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19). Published 2021. Accessed June 24, 2021. http://labeling.pfizer.com/ShowLabeling.aspx?id=14471&format=pdf&#page=14

Janssen Pharmaceutical Companies. Fact sheet for healthcare providers administering vaccine (vaccination providers) Emergency Use Authorization (EUA) of the Janssen COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19). Published 2021. Accessed June 24, 2021. https://www.janssenlabels.com/emergency-use-authorization/Janssen+COVID-19+Vaccine-HCP-fact-sheet.pdf

Latex Drugs. 2RPh. Published 2005. Accessed June 16, 2021. http://latexdrugs.com/

Jackson EM Arnette JA Martin ML Tahir WM Frost-Arner L Edlich RF. A global inventory of hospitals using powder-free gloves: a search for principled medical leadership. J Emerg Med. 2000;18(2):241-246. doi:10.1016/s0736-4679(99)00202-4